# NINTEDANIB
> **ANDA218472** · Abbreviated New Drug Application (Generic) · Sponsor: HUMANWELL PURACAP PHARMACEUTICALS (WUHAN) CO., LTD · Approved 2026-03-05
## Drug
- **FDA Application Number:** ANDA218472
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NINTEDANIB
- **Generic name:** Nintedanib
- **Active ingredients:** NINTEDANIB
- **Dosage form:** CAPSULE
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** HUMANWELL PURACAP PHARMACEUTICALS (WUHAN) CO., LTD
- **First approval:** 2026-03-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218472)
---
*MORVS · CC0 1.0*